Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma

Authors

Joyce N. Barlin
Barb Mahar
Asahr Ata
Beatrice Cormier
David Michelin
Ritu Salani
Floor Backes
Kimberly Levison, Greater Baltimore Medical Center (GBMC)
Leigh Ann Cantrell
Lori Weinberg
Allison Wagreich
Duncan Savage
Christian Gasson
Kyle Denniston
Jovana Martin
Timothy McElrath
Patrick F. Timmins

Document Type

Article

Publication Title

Gynecology Oncology

First Page

63

Last Page

69

DOI

10.1016/j.ygyno.2023.11.012

Publication Date

Winter 1-2024

Recommended Citation

Barlin JN, Mahar B, Ata A, Cormier B, Michelin D, Salani R, Backes F, Levinson K, Cantrell LA, Weinberg L, Wagreich A, Savage D, Gasson C, Denniston K, Martin J, McElrath T, Timmins PF. Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma. Gynecol Oncol. 2024 Jan;180:63-69. doi: 10.1016/j.ygyno.2023.11.012. Epub 2023 Dec 5. PMID: 38052110.